ASX Announcements

    COH - Profile Plus FDA Approval
    COH Hosts Capital Markets Day 10 May 2019
    Cochlear announces launch of Nucleus Profile Plus implant
    UK cochlear implant criteria change
    Becoming a substantial holder from PNI
    Becoming a substantial holder
    Change of Director's Interest Notice
    COH Half Year Results Analyst - 19.02.2019
    COH Half Year Results Media Release - 19.02.2019
    Dividend/Distribution - COH
    Half Yearly Report and Accounts
    Appendix 3B

      Subscribe to Email Alerts